Longitudinal Study of People Presenting for First Treatment of a Mood Disorder

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2005 by McMaster University.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Ontario Mental Health Foundation
Canadian Institutes of Health Research (CIHR)
AstraZeneca
Information provided by (Responsible Party):
McMaster University
ClinicalTrials.gov Identifier:
NCT01529905
First received: February 7, 2012
Last updated: February 8, 2012
Last verified: June 2005
  Purpose

The goal of this project is to study the course and outcome of illness in individuals who present with a first episode of depression or mania, or who have a recurrent disorder but have never received treatment. We plan to examine psychological, physical, social and environmental factors that may affect long-term outcome in these disorders


Condition
Major Depression
Bipolar Disorder

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Longitudinal Study of Individuals Presenting With a First Treated Episode of Depression of Mania (First Episode Project)

Resource links provided by NLM:


Further study details as provided by McMaster University:

Estimated Enrollment: 200
Study Start Date: June 1999
Estimated Study Completion Date: June 2014
Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   16 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

patients who present to a tertiary care clinic for first treatment of depression or mania

Criteria

Inclusion Criteria:

  • Primary Mood Disorder,
  • Age 16-50
  • No previous treatment with psychotropic medication (may have had a max. of 5 days treatment with antidepressants/mood stabilizer &/or they may have Haldol &/or Lorazepam for clear restraint)

Exclusion Criteria:

  • History of CNS illness (except migraines),
  • Thyroid Disease,
  • Neoplastic illness
  • History of, or currently being treated for, Anorexia or Bulimia
  • History of Traumatic Brain Injury
  • Current treatment of Attention-Deficit Hyperactivity Disorder (ADHD)
  • Previous diagnosis of OCD or primary Anxiety disorder
  • Axis-II diagnosis that would suggest non-responsiveness to pharmacotherapy.
  • Substance dependence
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01529905

Contacts
Contact: Helen Begin, RN 905-522-1155 ext 5409 hbegin@stjosham.on.ca

Locations
Canada, Ontario
St. Joseph's Healthcare, Centre for Mountain Health Services Recruiting
Hamilton, Ontario, Canada, L8N 3K7
Contact: Helen Begin, RN    905-522-1155 ext 5426    hbegin@stjosham.on.ca   
Sponsors and Collaborators
McMaster University
Ontario Mental Health Foundation
Canadian Institutes of Health Research (CIHR)
AstraZeneca
Investigators
Principal Investigator: Glenda MacQueen, MD, PhD McMaster University
  More Information

Publications:
Responsible Party: McMaster University
ClinicalTrials.gov Identifier: NCT01529905     History of Changes
Other Study ID Numbers: 99-1715
Study First Received: February 7, 2012
Last Updated: February 8, 2012
Health Authority: Canada: Health Canada

Keywords provided by McMaster University:
depression
mania
bipolar
outcome
cognitive

Additional relevant MeSH terms:
Depression
Depressive Disorder
Bipolar Disorder
Depressive Disorder, Major
Disease
Behavioral Symptoms
Mood Disorders
Mental Disorders
Affective Disorders, Psychotic
Pathologic Processes

ClinicalTrials.gov processed this record on October 19, 2014